About Us Services Careers FAQ Contact Us 0
Home Pharmaceuticals Antisense and RNAi Therapeutics Market Size to Grow at a CAGR of 17.4% by 2032

Antisense and RNAi Therapeutics Market Size, Share & Trends Analysis Report By Technology (RNA Interference, siRNA, miRNA, Antisense RNA), By Application (Oncology, Cardiovascular Diseases (CVDs), Respiratory Disorders, Renal Diseases, Neurodegenerative Disorders, Genetic Disorders, Infectious Diseases, Others), By Route of Administration (Intravenous Route, Subcutaneous Route, Intrathecal Route, Pulmonary Delivery, Intraperitoneal Injection, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRPH56079DR
Author : Straits Research

Market Segmentation

  1. Antisense and RNAi Therapeutics Market, By Technology (2020-2032)
    1. RNA Interference
    2. siRNA
    3. miRNA
    4. Antisense RNA
  2. Antisense and RNAi Therapeutics Market, By Application (2020-2032)
    1. Oncology
    2. Cardiovascular Diseases (CVDs)
    3. Respiratory Disorders
    4. Renal Diseases
    5. Neurodegenerative Disorders
    6. Genetic Disorders
    7. Infectious Diseases
    8. Others
  3. Antisense and RNAi Therapeutics Market, By Route of Administration (2020-2032)
    1. Intravenous Route
    2. Subcutaneous Route
    3. Intrathecal Route
    4. Pulmonary Delivery
    5. Intraperitoneal Injection
    6. Others
    1. North America
      1. North America Antisense and RNAi Therapeutics Market, By Technology
        1. RNA Interference
          1. siRNA
            1. miRNA
              1. Antisense RNA
              2. North America Antisense and RNAi Therapeutics Market, By Application
                1. Oncology
                  1. Cardiovascular Diseases (CVDs)
                    1. Respiratory Disorders
                      1. Renal Diseases
                        1. Neurodegenerative Disorders
                          1. Genetic Disorders
                            1. Infectious Diseases
                              1. Others
                              2. North America Antisense and RNAi Therapeutics Market, By Route of Administration
                                1. Intravenous Route
                                  1. Subcutaneous Route
                                    1. Intrathecal Route
                                      1. Pulmonary Delivery
                                        1. Intraperitoneal Injection
                                          1. Others
                                          2. U.S.
                                            1. U.S. Antisense and RNAi Therapeutics Market, By Technology
                                              1. RNA Interference
                                                1. siRNA
                                                  1. miRNA
                                                    1. Antisense RNA
                                                    2. U.S. Antisense and RNAi Therapeutics Market, By Application
                                                      1. Oncology
                                                        1. Cardiovascular Diseases (CVDs)
                                                          1. Respiratory Disorders
                                                            1. Renal Diseases
                                                              1. Neurodegenerative Disorders
                                                                1. Genetic Disorders
                                                                  1. Infectious Diseases
                                                                    1. Others
                                                                    2. U.S. Antisense and RNAi Therapeutics Market, By Route of Administration
                                                                      1. Intravenous Route
                                                                        1. Subcutaneous Route
                                                                          1. Intrathecal Route
                                                                            1. Pulmonary Delivery
                                                                              1. Intraperitoneal Injection
                                                                                1. Others
                                                                              2. Canada
                                                                            2. Europe
                                                                              1. Europe Antisense and RNAi Therapeutics Market, By Technology
                                                                                1. RNA Interference
                                                                                  1. siRNA
                                                                                    1. miRNA
                                                                                      1. Antisense RNA
                                                                                      2. Europe Antisense and RNAi Therapeutics Market, By Application
                                                                                        1. Oncology
                                                                                          1. Cardiovascular Diseases (CVDs)
                                                                                            1. Respiratory Disorders
                                                                                              1. Renal Diseases
                                                                                                1. Neurodegenerative Disorders
                                                                                                  1. Genetic Disorders
                                                                                                    1. Infectious Diseases
                                                                                                      1. Others
                                                                                                      2. Europe Antisense and RNAi Therapeutics Market, By Route of Administration
                                                                                                        1. Intravenous Route
                                                                                                          1. Subcutaneous Route
                                                                                                            1. Intrathecal Route
                                                                                                              1. Pulmonary Delivery
                                                                                                                1. Intraperitoneal Injection
                                                                                                                  1. Others
                                                                                                                  2. U.K.
                                                                                                                    1. U.K. Antisense and RNAi Therapeutics Market, By Technology
                                                                                                                      1. RNA Interference
                                                                                                                        1. siRNA
                                                                                                                          1. miRNA
                                                                                                                            1. Antisense RNA
                                                                                                                            2. U.K. Antisense and RNAi Therapeutics Market, By Application
                                                                                                                              1. Oncology
                                                                                                                                1. Cardiovascular Diseases (CVDs)
                                                                                                                                  1. Respiratory Disorders
                                                                                                                                    1. Renal Diseases
                                                                                                                                      1. Neurodegenerative Disorders
                                                                                                                                        1. Genetic Disorders
                                                                                                                                          1. Infectious Diseases
                                                                                                                                            1. Others
                                                                                                                                            2. U.K. Antisense and RNAi Therapeutics Market, By Route of Administration
                                                                                                                                              1. Intravenous Route
                                                                                                                                                1. Subcutaneous Route
                                                                                                                                                  1. Intrathecal Route
                                                                                                                                                    1. Pulmonary Delivery
                                                                                                                                                      1. Intraperitoneal Injection
                                                                                                                                                        1. Others
                                                                                                                                                      2. Germany
                                                                                                                                                      3. France
                                                                                                                                                      4. Spain
                                                                                                                                                      5. Italy
                                                                                                                                                      6. Russia
                                                                                                                                                      7. Nordic
                                                                                                                                                      8. Benelux
                                                                                                                                                      9. Rest of Europe
                                                                                                                                                    2. APAC
                                                                                                                                                      1. APAC Antisense and RNAi Therapeutics Market, By Technology
                                                                                                                                                        1. RNA Interference
                                                                                                                                                          1. siRNA
                                                                                                                                                            1. miRNA
                                                                                                                                                              1. Antisense RNA
                                                                                                                                                              2. APAC Antisense and RNAi Therapeutics Market, By Application
                                                                                                                                                                1. Oncology
                                                                                                                                                                  1. Cardiovascular Diseases (CVDs)
                                                                                                                                                                    1. Respiratory Disorders
                                                                                                                                                                      1. Renal Diseases
                                                                                                                                                                        1. Neurodegenerative Disorders
                                                                                                                                                                          1. Genetic Disorders
                                                                                                                                                                            1. Infectious Diseases
                                                                                                                                                                              1. Others
                                                                                                                                                                              2. APAC Antisense and RNAi Therapeutics Market, By Route of Administration
                                                                                                                                                                                1. Intravenous Route
                                                                                                                                                                                  1. Subcutaneous Route
                                                                                                                                                                                    1. Intrathecal Route
                                                                                                                                                                                      1. Pulmonary Delivery
                                                                                                                                                                                        1. Intraperitoneal Injection
                                                                                                                                                                                          1. Others
                                                                                                                                                                                          2. China
                                                                                                                                                                                            1. China Antisense and RNAi Therapeutics Market, By Technology
                                                                                                                                                                                              1. RNA Interference
                                                                                                                                                                                                1. siRNA
                                                                                                                                                                                                  1. miRNA
                                                                                                                                                                                                    1. Antisense RNA
                                                                                                                                                                                                    2. China Antisense and RNAi Therapeutics Market, By Application
                                                                                                                                                                                                      1. Oncology
                                                                                                                                                                                                        1. Cardiovascular Diseases (CVDs)
                                                                                                                                                                                                          1. Respiratory Disorders
                                                                                                                                                                                                            1. Renal Diseases
                                                                                                                                                                                                              1. Neurodegenerative Disorders
                                                                                                                                                                                                                1. Genetic Disorders
                                                                                                                                                                                                                  1. Infectious Diseases
                                                                                                                                                                                                                    1. Others
                                                                                                                                                                                                                    2. China Antisense and RNAi Therapeutics Market, By Route of Administration
                                                                                                                                                                                                                      1. Intravenous Route
                                                                                                                                                                                                                        1. Subcutaneous Route
                                                                                                                                                                                                                          1. Intrathecal Route
                                                                                                                                                                                                                            1. Pulmonary Delivery
                                                                                                                                                                                                                              1. Intraperitoneal Injection
                                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                              2. Korea
                                                                                                                                                                                                                              3. Japan
                                                                                                                                                                                                                              4. India
                                                                                                                                                                                                                              5. Australia
                                                                                                                                                                                                                              6. Singapore
                                                                                                                                                                                                                              7. Taiwan
                                                                                                                                                                                                                              8. South East Asia
                                                                                                                                                                                                                              9. Rest of Asia-Pacific
                                                                                                                                                                                                                            2. Middle East and Africa
                                                                                                                                                                                                                              1. Middle East and Africa Antisense and RNAi Therapeutics Market, By Technology
                                                                                                                                                                                                                                1. RNA Interference
                                                                                                                                                                                                                                  1. siRNA
                                                                                                                                                                                                                                    1. miRNA
                                                                                                                                                                                                                                      1. Antisense RNA
                                                                                                                                                                                                                                      2. Middle East and Africa Antisense and RNAi Therapeutics Market, By Application
                                                                                                                                                                                                                                        1. Oncology
                                                                                                                                                                                                                                          1. Cardiovascular Diseases (CVDs)
                                                                                                                                                                                                                                            1. Respiratory Disorders
                                                                                                                                                                                                                                              1. Renal Diseases
                                                                                                                                                                                                                                                1. Neurodegenerative Disorders
                                                                                                                                                                                                                                                  1. Genetic Disorders
                                                                                                                                                                                                                                                    1. Infectious Diseases
                                                                                                                                                                                                                                                      1. Others
                                                                                                                                                                                                                                                      2. Middle East and Africa Antisense and RNAi Therapeutics Market, By Route of Administration
                                                                                                                                                                                                                                                        1. Intravenous Route
                                                                                                                                                                                                                                                          1. Subcutaneous Route
                                                                                                                                                                                                                                                            1. Intrathecal Route
                                                                                                                                                                                                                                                              1. Pulmonary Delivery
                                                                                                                                                                                                                                                                1. Intraperitoneal Injection
                                                                                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                                                                                  2. UAE
                                                                                                                                                                                                                                                                    1. UAE Antisense and RNAi Therapeutics Market, By Technology
                                                                                                                                                                                                                                                                      1. RNA Interference
                                                                                                                                                                                                                                                                        1. siRNA
                                                                                                                                                                                                                                                                          1. miRNA
                                                                                                                                                                                                                                                                            1. Antisense RNA
                                                                                                                                                                                                                                                                            2. UAE Antisense and RNAi Therapeutics Market, By Application
                                                                                                                                                                                                                                                                              1. Oncology
                                                                                                                                                                                                                                                                                1. Cardiovascular Diseases (CVDs)
                                                                                                                                                                                                                                                                                  1. Respiratory Disorders
                                                                                                                                                                                                                                                                                    1. Renal Diseases
                                                                                                                                                                                                                                                                                      1. Neurodegenerative Disorders
                                                                                                                                                                                                                                                                                        1. Genetic Disorders
                                                                                                                                                                                                                                                                                          1. Infectious Diseases
                                                                                                                                                                                                                                                                                            1. Others
                                                                                                                                                                                                                                                                                            2. UAE Antisense and RNAi Therapeutics Market, By Route of Administration
                                                                                                                                                                                                                                                                                              1. Intravenous Route
                                                                                                                                                                                                                                                                                                1. Subcutaneous Route
                                                                                                                                                                                                                                                                                                  1. Intrathecal Route
                                                                                                                                                                                                                                                                                                    1. Pulmonary Delivery
                                                                                                                                                                                                                                                                                                      1. Intraperitoneal Injection
                                                                                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                                                                                                                                      1. LATAM Antisense and RNAi Therapeutics Market, By Technology
                                                                                                                                                                                                                                                                                                        1. RNA Interference
                                                                                                                                                                                                                                                                                                          1. siRNA
                                                                                                                                                                                                                                                                                                            1. miRNA
                                                                                                                                                                                                                                                                                                              1. Antisense RNA
                                                                                                                                                                                                                                                                                                              2. LATAM Antisense and RNAi Therapeutics Market, By Application
                                                                                                                                                                                                                                                                                                                1. Oncology
                                                                                                                                                                                                                                                                                                                  1. Cardiovascular Diseases (CVDs)
                                                                                                                                                                                                                                                                                                                    1. Respiratory Disorders
                                                                                                                                                                                                                                                                                                                      1. Renal Diseases
                                                                                                                                                                                                                                                                                                                        1. Neurodegenerative Disorders
                                                                                                                                                                                                                                                                                                                          1. Genetic Disorders
                                                                                                                                                                                                                                                                                                                            1. Infectious Diseases
                                                                                                                                                                                                                                                                                                                              1. Others
                                                                                                                                                                                                                                                                                                                              2. LATAM Antisense and RNAi Therapeutics Market, By Route of Administration
                                                                                                                                                                                                                                                                                                                                1. Intravenous Route
                                                                                                                                                                                                                                                                                                                                  1. Subcutaneous Route
                                                                                                                                                                                                                                                                                                                                    1. Intrathecal Route
                                                                                                                                                                                                                                                                                                                                      1. Pulmonary Delivery
                                                                                                                                                                                                                                                                                                                                        1. Intraperitoneal Injection
                                                                                                                                                                                                                                                                                                                                          1. Others
                                                                                                                                                                                                                                                                                                                                          2. Brazil
                                                                                                                                                                                                                                                                                                                                            1. Brazil Antisense and RNAi Therapeutics Market, By Technology
                                                                                                                                                                                                                                                                                                                                              1. RNA Interference
                                                                                                                                                                                                                                                                                                                                                1. siRNA
                                                                                                                                                                                                                                                                                                                                                  1. miRNA
                                                                                                                                                                                                                                                                                                                                                    1. Antisense RNA
                                                                                                                                                                                                                                                                                                                                                    2. Brazil Antisense and RNAi Therapeutics Market, By Application
                                                                                                                                                                                                                                                                                                                                                      1. Oncology
                                                                                                                                                                                                                                                                                                                                                        1. Cardiovascular Diseases (CVDs)
                                                                                                                                                                                                                                                                                                                                                          1. Respiratory Disorders
                                                                                                                                                                                                                                                                                                                                                            1. Renal Diseases
                                                                                                                                                                                                                                                                                                                                                              1. Neurodegenerative Disorders
                                                                                                                                                                                                                                                                                                                                                                1. Genetic Disorders
                                                                                                                                                                                                                                                                                                                                                                  1. Infectious Diseases
                                                                                                                                                                                                                                                                                                                                                                    1. Others
                                                                                                                                                                                                                                                                                                                                                                    2. Brazil Antisense and RNAi Therapeutics Market, By Route of Administration
                                                                                                                                                                                                                                                                                                                                                                      1. Intravenous Route
                                                                                                                                                                                                                                                                                                                                                                        1. Subcutaneous Route
                                                                                                                                                                                                                                                                                                                                                                          1. Intrathecal Route
                                                                                                                                                                                                                                                                                                                                                                            1. Pulmonary Delivery
                                                                                                                                                                                                                                                                                                                                                                              1. Intraperitoneal Injection
                                                                                                                                                                                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                                                                                                                                                                              2. Mexico
                                                                                                                                                                                                                                                                                                                                                                              3. Argentina
                                                                                                                                                                                                                                                                                                                                                                              4. Chile
                                                                                                                                                                                                                                                                                                                                                                              5. Colombia
                                                                                                                                                                                                                                                                                                                                                                              6. Rest of LATAM
                                                                                                                                                                                                                                                                                                                                                                          Straits Research - Access Portal
                                                                                                                                                                                                                                                                                                                                                                          • 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
                                                                                                                                                                                                                                                                                                                                                                          • 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
                                                                                                                                                                                                                                                                                                                                                                          Get Free Access


                                                                                                                                                                                                                                                                                                                                                                          We are featured on :

                                                                                                                                                                                                                                                                                                                                                                          www.straitsresearch.com
                                                                                                                                                                                                                                                                                                                                                                          © Copyright . All rights Reserved.